Why the study?
Does PAI-1 deficiency prevent hypertension and vascular fibrosis in response to long-term NOS inhibition in male mice?
Population
PAI-1-deficient (PAI-1(-/-)) and wild-type (WT) male mice (N=6 per group)
Comparison
PAI-1 deficiency with long-term nitric oxide… vs Wild-type mice with long-term NOS inhibition by…
Design
Preclinical
Follow-up
8 weeks
Authors
Loading...
PAI-1 deficiency attenuates hypertension in this model; hypothesis-generating for therapeutic targeting and requires human validation before any clinical consideration.
Does PAI-1 deficiency prevent hypertension and vascular fibrosis in response to long-term NOS inhibition in male mice?
PAI-1 deficiency protects against structural vascular changes and hypertension induced by long-term NOS inhibition in mice, suggesting vascular PAI-1 as a potential therapeutic target.
Kaikita et al. (2001) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: